Reaffirming Kinase Inhibitors in Treatment of Inflammatory Skin Diseases: JAK Inhibitors & Beyond

Time: 3:30 pm
day: Day Two


  • Reflecting on lessons from the use of JAK inhibitors in dermatology to cultivate targeted skin delivery to improve selectivity and safety profiles
  • Identifying new druggable targets to deliver for unmet clinical needs
  • Optimizing translational approaches to identify early response biomarkers to inform clinical strategy